Engineered cardiac transcription factor restores vision and reduces frailty in aging mice
A genome-scale screen in retinal cells identified NKX2-5 variants that conferred oxidative resilience and improved physical function without detectable toxicity.

Our read
Interventions- Studied:
- Preprint: experiments in mice (14 months)
- Stake:
- An author holds shares in Life Biosciences.
Editor of record: Boris Djordjevic · AgingResearch.News
In a new preprint, researchers tested retinal pigment epithelium cells and aging mice to discover genes that confer resistance to oxidative damage. Using an unbiased, genome-scale open reading frame screen, the team identified nine protective factors, including antioxidant genes and a regulator of epithelial-to-mesenchymal transition. Three candidates reduced transcriptomic age, notably the cardiac transcription factor NKX2-5. Domain dissection revealed that its homeodomain was dispensable, enabling the development of an engineered variant, NKX2-5ΔHD, which retained protective activity with no detectable toxicity over 14 months. Subretinal delivery of NKX2-5ΔHD restored electrophysiological and visual function in middle-aged mice, while systemic administration improved grip strength and lowered frailty scores in late-aged mice.
Why it matters
The findings show that unbiased gain-of-function screening can identify resilience factors from non-retinal lineages that mitigate oxidative damage and tissue decline during aging.
Caveats
The study was conducted exclusively in cell cultures and mice, and the results appear in a preprint that has not yet completed peer review.
The paper
Whitehead Institute for Biomedical Research
bioRxiv, Sep 30, 2026, Open access, Preprint, not yet peer-reviewed


Comments
Be the first to comment.